Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection
Conditions: CMV Infection Interventions: Drug: Letermovir 480 MG; Drug: Ganciclovir Sponsors: Hospital do Rim e Hipertens ão Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Quantiferon CMV to Identify Treatment Need For Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)
Conditions: Solid Organ Transplantation (Heart, Kidney, Lung, Liver); Cytomegalovirus Infections Interventions: Diagnostic Test: Quantiferon CMV (assay that determine the presence of CMV-specific T lymphocytes).; Other: Communication of the result of the QF-CMV to the clinician in charge Sponsors: University Hospital, Grenoble Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
HCMV Breakthrough Infections During Letermovir Prophylaxis
Conditions: Cytomegalovirus Infections; Cytomegalovirus Viremia; Hematopoietic Stem Cell Transplantation Interventions: Diagnostic Test: Determination of HCMV DNA in plasma after DNAse digestion.; Diagnostic Test: Determination of HCMV DNA in blood or plasma. Sponsors: Foundation IRCCS San Matteo Hospital; Ministero della Salute, Italy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Non Primary HCMV Infection: Natural History and Immune Response
Conditions: Cytomegalovirus Infections Sponsors: Foundation IRCCS San Matteo Hospital; Universit à degli Studi di Pavia; Merck Sharp& Dohme LLC; Fondazione Regionale per la Ricerca Biomedica (FRRB) - Regione Lombardia Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections
Conditions: Cytomegalovirus Infection Interventions: Drug: Letermovir; Drug: Valganciclovir; Drug: Letermovir placebo Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
The Link Between Human Cytomegalovirus Gene Expression and Glutamate Level in Migraine;Relation to Vitamin D Deficiency
Conditions: Migraine Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
Conditions: Cytomegalovirus (CMV); Kidney Disease; Kidney Failure Interventions: Other: No Intervention Sponsors: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Argentina
Conditions: Cytomegalovirus (CMV) Interventions: Other: No Intervention Sponsors: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
Conditions: Glioblastoma Multiforme; Astrocytoma, Grade IV Interventions: Biological: Allogeneic cytomegalovirus-specific T cells; Drug: Pembrolizumab Sponsors: Queensland Institute of Medical Research; CUREator; Merck Sharp& Dohme LLC; The Newro Foundation; Royal Brisbane and Women ' s Hospital; Princess Alexandra Hospital, Brisbane, Australia; Austin Hospital, Melbourne Australia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
A Phase I Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants
Conditions: Cytomegalovirus Infections Interventions: Biological: SPYVAC01 Sponsors: SpyBiotech Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients
Conditions: Cytomegalovirus Infection Interventions: Biological: mRNA-1647; Biological: Placebo Sponsors: ModernaTX, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
Conditions: Glioblastoma Interventions: Drug: PEP-CMV vaccine Sponsors: Charlotte Lemech; The University of New South Wales Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus
Conditions: Congenital Cytomegalovirus Infection Interventions: Drug: Letermovir Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Conditions: Liver Transplant Interventions: Drug: CMV-MVA Triplex; Drug: Placebo for CMV-MVA Triplex Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients
Conditions: Cytomegalovirus Infections; Transplant-Related Disorder Interventions: Drug: Letermovir 480 MG [Prevymis] Sponsors: University of Pennsylvania; Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
